Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
i-PRF Intrauterine Perfusion for Endometrial Regeneration in Moderate to Severe Intrauterine Adhesions
NCT07536971Not yet recruiting
- Sponsor
- Beijing Obstetrics and Gynecology Hospital
- Start
- May 2026
- Primary completion
- Dec 2028
- Modality
- Device-based Delivery
- Countries
- 1
01
Overview
Randomised trial of injectable platelet-rich fibrin in Intrauterine Adhesions (IUA) (2 arms), sponsored by Beijing Obstetrics and Gynecology Hospital. Primary endpoint: Clinical Pregnancy Rate at 2 years. Planned start May 2026; status: not yet recruiting.
02
Drugs
injectable platelet-rich fibrin
03
Conditions
Intrauterine Adhesions (IUA)
Beyond the preview
Go deeper on NCT07536971.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07536971.